A look ahead for managed care pharmacy in 2006.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Diane Giaquinta.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The time for drug manufacturers to educate MCOs about new drugs is not a month before obtaining Food and Drug Administration approval. Today, as Dr. Giaquinta explains, it is imperative that pharmaceutical companies present information about their pipeline products three to five years before drug launch.